Background Cell transplantation offers a potential therapeutic approach to the repair and
regeneration of damaged vascular and cardiac tissue after acute myocardial infarction (AMI) …

Cell-based therapy is a promising option for treatment of ischemic diseases. Several cell
types have experimentally been shown to increase the functional recovery of the heart after …

Background Previous studies have shown improvement in left ventricular function after
intracoronary injection of autologous cells derived from bone marrow (BMC) in the acute …

Aim The recently published REPAIR-AMI and ASTAMI trial showed differences in contractile
recovery of left ventricular function after infusion of bone marrow-derived cells in acute …

This article provides information and a commentary on trials presented at the American
Heart Association meeting held in November 2005, relevant to the pathophysiology …

The heart is a complex organ system composed of a highly diverse set of muscle and
nonmuscle cells. Understanding the pathways that drive the formation, migration, and …

BACKGROUND: The use of bone marrow concentrate (BMC) for treatment of
musculoskeletal disorders has become increasingly popular over the last several years, as …

Bone marrow-derived CD34+ cells are a well-characterized population of stem cells that
have traditionally been used clinically to reconstitute the hematopoietic system after …

Acute myocardial infarction is the leading cause of morbidity and mortality in the adult
population of developed and developing nations. Although the prompt restoration of …

Cardiovascular disease remains the leading cause of death worldwide. Acute ischaemic
injury and chronic cardiomyopathies lead to permanent loss of cardiac tissue and ultimately …